Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Hammel

Showing results (11-20 of 240) with videos related to

Pageof 24
Sort By:
Gastroenterologie Clinique Et Biologique|April 22, 2003
[Can the natural history of diabetes be changed in chronic pancreatitis?]David Malka, Pascal Hammel
Scandinavian Journal of Gastroenterology|March 4, 2015
Pancreatic neuroendocrine tumors in von Hippel-Lindau diseaseLouis de Mestier, Pascal Hammel
JAMA|October 5, 2016
Radiation Therapy Deviations in Trial of Locally Advanced Prostate Cancer-ReplyFlorence Huguet, David Goldstein, Pascal Hammel
Presse Medicale (Paris, France : 1983)|May 11, 2007
[Autoimmune pancreatitis]Philippe Lévy, Pascal Hammel, Philippe Ruszniewski
Gut|November 22, 2008
Diagnostic challenge in autoimmune pancreatitis: beware of shipwreck!Philippe Lévy, Pascal Hammel, Philippe Ruszniewski
JAMA Oncology|January 26, 2023
Overall Survival With Adjuvant mFOLFIRINOX for Pancreatic Cancer-ReplyThierry Conroy, Florence Castan, Pascal Hammel
Gastrointestinal Endoscopy|January 31, 2009
Technique of pancreatic cyst aspirationLaurent Palazzo, Dermot O'Toole, Pascal Hammel
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|June 17, 2017
5-Fluorouracil biomarkers in pancreatic neuroendocrine tumoursLouis de Mestier, Jérôme Cros, Pascal Hammel
Trials|October 14, 2015
Rationale and design of the Adapted Physical Activity in advanced Pancreatic Cancer patients (APACaP) GERCOR (Groupe Coopérateur Multidisciplinaire en Oncologie) trial: study protocol for a randomized controlled trialCindy Neuzillet, Mathieu Vergnault, Franck Bonnetain, et al.
Targeted Oncology|November 14, 2009
Sunitinib paves the way for targeted therapies in neuroendocrine tumorsEric Raymond, Sandrine Faivre, Pascal Hammel, et al.
Pageof 24

Showing results (11-20 of 240) with videos related to

Sort By:
Pageof 24
Gastroenterologie Clinique Et Biologique|April 22, 2003
[Can the natural history of diabetes be changed in chronic pancreatitis?]David Malka, Pascal Hammel
Scandinavian Journal of Gastroenterology|March 4, 2015
Pancreatic neuroendocrine tumors in von Hippel-Lindau diseaseLouis de Mestier, Pascal Hammel
JAMA|October 5, 2016
Radiation Therapy Deviations in Trial of Locally Advanced Prostate Cancer-ReplyFlorence Huguet, David Goldstein, Pascal Hammel
Presse Medicale (Paris, France : 1983)|May 11, 2007
[Autoimmune pancreatitis]Philippe Lévy, Pascal Hammel, Philippe Ruszniewski
Gut|November 22, 2008
Diagnostic challenge in autoimmune pancreatitis: beware of shipwreck!Philippe Lévy, Pascal Hammel, Philippe Ruszniewski
JAMA Oncology|January 26, 2023
Overall Survival With Adjuvant mFOLFIRINOX for Pancreatic Cancer-ReplyThierry Conroy, Florence Castan, Pascal Hammel
Gastrointestinal Endoscopy|January 31, 2009
Technique of pancreatic cyst aspirationLaurent Palazzo, Dermot O'Toole, Pascal Hammel
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|June 17, 2017
5-Fluorouracil biomarkers in pancreatic neuroendocrine tumoursLouis de Mestier, Jérôme Cros, Pascal Hammel
Trials|October 14, 2015
Rationale and design of the Adapted Physical Activity in advanced Pancreatic Cancer patients (APACaP) GERCOR (Groupe Coopérateur Multidisciplinaire en Oncologie) trial: study protocol for a randomized controlled trialCindy Neuzillet, Mathieu Vergnault, Franck Bonnetain, et al.
Targeted Oncology|November 14, 2009
Sunitinib paves the way for targeted therapies in neuroendocrine tumorsEric Raymond, Sandrine Faivre, Pascal Hammel, et al.
Pageof 24